芬特明 (Chinese Wikipedia)

Analysis of information sources in references of the Wikipedia article "芬特明" in Chinese language version.

refsWebsite

Global rank Chinese rank

15web.archive.org

1^st place

7nih.gov

4^th place

5^th place

7doi.org

2^nd place

23^rd place

4books.google.com

3^rd place

8^th place

4drugs.com

399^th place

208^th place

3fda.gov

447^th place

581^st place

2clincalc.com

3,912^th place

5,917^th place

2semanticscholar.org

11^th place

332^nd place

1tga.gov.au

3,984^th place

1,603^rd place

1in.gov.br

3,151^st place

low place

1filofetch.com

low place

1zenodo.org

621^st place

1,608^th place

1nytimes.com

7^th place

31^st place

books.google.com

Tarascon Pocket Pharmacopoeia 2017 Deluxe Lab-Coat Edition. Jones & Bartlett Learning. 2016: 7. ISBN 9781284118971 （英语）.
Sadock BJ, Sadock VA. Kaplan and Sadock's Pocket Handbook of Clinical Psychiatry. Lippincott Williams & Wilkins. 2010: 435. ISBN 9781605472645 （英语）.
Bagchi D, Preuss HG. Obesity: Epidemiology, Pathophysiology, and Prevention Second. CRC Press. 2012: 314 [2024-01-03]. ISBN 9781439854259. （原始内容存档于2023-12-23）（英语）.
Ryan DA, Bray GA. Sibutramine, Phentermine, and Diethylproprion: Sympathomimetic Drugs in the Management of Obesity. Bray GA, Bouchard C (编). Handbook of Obesity - Volume 2 Clinical Applications Fourth. Hoboken: Taylor and Francis. 2014: 234. ISBN 9781841849829.

clincalc.com

The Top 300 of 2020. ClinCalc. [2022-10-07]. （原始内容存档于2021-02-12）.
Phentermine - Drug Usage Statistics. ClinCalc. [2022-10-07]. （原始内容存档于2020-09-22）.

doi.org

Hagel JM, Krizevski R, Marsolais F, Lewinsohn E, Facchini PJ. Biosynthesis of amphetamine analogs in plants. Trends in Plant Science. July 2012, 17 (7): 404–412. PMID 22502775. doi:10.1016/j.tplants.2012.03.004.
Glazer G. Long-term pharmacotherapy of obesity 2000: a review of efficacy and safety. Archives of Internal Medicine. August 2001, 161 (15): 1814–1824. PMID 11493122. doi:10.1001/archinte.161.15.1814 .
Haslam D. Weight management in obesity - past and present. International Journal of Clinical Practice. March 2016, 70 (3): 206–217. PMC 4832440 . PMID 26811245. doi:10.1111/ijcp.12771.
Barak LS, Salahpour A, Zhang X, Masri B, Sotnikova TD, Ramsey AJ, et al. Pharmacological characterization of membrane-expressed human trace amine-associated receptor 1 (TAAR1) by a bioluminescence resonance energy transfer cAMP biosensor. Molecular Pharmacology. September 2008, 74 (3): 585–594. PMC 3766527 . PMID 18524885. doi:10.1124/mol.108.048884. we confirmed agonistic activity at human TAAR1 of several other compounds, including the trace amines octopamine and tryptamine, the amphetamine derivatives l-amphetamine, d-methamphetamine, (+)-MDMA, and phentermine, and the catecholamine metabolites 3-MT and 4-MT (Bunzow et al., 2001; Lindemann and Hoener, 2005; Reese et al., 2007; Wainscott et al., 2007; Wolinsky et al., 2007; Xie and Miller, 2007; Xie et al., 2007).
Rothman RB, Baumann MH, Dersch CM, Romero DV, Rice KC, Carroll FI, Partilla JS. Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse. January 2001, 39 (1): 32–41. PMID 11071707. S2CID 15573624. doi:10.1002/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3.
Weigle DS. Pharmacological therapy of obesity: past, present, and future. The Journal of Clinical Endocrinology and Metabolism. June 2003, 88 (6): 2462–2469. PMID 12788841. doi:10.1210/jc.2003-030151 .
Rueda-Clausen CF, Padwal RS, Sharma AM. New pharmacological approaches for obesity management. Nature Reviews. Endocrinology. August 2013, 9 (8): 467–478 [2024-01-03]. PMID 23752772. S2CID 20072687. doi:10.1038/nrendo.2013.113. （原始内容存档 (PDF)于2021-08-28）.

drugs.com

Phentermine Monograph for Professionals. Drugs.com. American Society of Health-System Pharmacists. [2019-04-13]. （原始内容存档于2019-06-07）.
Phentermine and topiramate Uses, Side Effects & Warnings. Drugs.com. [2019-04-13]. （原始内容存档于2019-04-13）（英语）.
Phentermine Use During Pregnancy. Drugs.com. [2019-04-13]. （原始内容存档于2019-04-13）（英语）.
International brands for phentermine. Drugs.com. [2016-10-13]. （原始内容存档于2016-10-13）.

fda.gov

FDA Announces Withdrawal Fenfluramine and Dexfenfluramine (Fen-Phen). Fda.gov. [2013-07-12]. （原始内容存档于2009-11-04）.
FDA approves weight-management drug Qsymia. FDA. 2012-07-17 [2024-01-03]. （原始内容存档于2017-01-18）.

accessdata.fda.gov

Phentermine label at FDA (Last updated: January 2012). FDA. [2016-10-13]. （原始内容存档 (PDF)于2017-01-18）.

filofetch.com

Convention on Psychotropic Substances 互联网档案馆的存檔，存档日期2014-03-14.

in.gov.br

Anvisa. RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control]. Diário Oficial da União. 2023-03-31 (2023-04-04) [2023-08-16]. （原始内容存档于2023-08-03）（巴西葡萄牙语）.

nih.gov

ncbi.nlm.nih.gov

Hagel JM, Krizevski R, Marsolais F, Lewinsohn E, Facchini PJ. Biosynthesis of amphetamine analogs in plants. Trends in Plant Science. July 2012, 17 (7): 404–412. PMID 22502775. doi:10.1016/j.tplants.2012.03.004.
Glazer G. Long-term pharmacotherapy of obesity 2000: a review of efficacy and safety. Archives of Internal Medicine. August 2001, 161 (15): 1814–1824. PMID 11493122. doi:10.1001/archinte.161.15.1814 .
Haslam D. Weight management in obesity - past and present. International Journal of Clinical Practice. March 2016, 70 (3): 206–217. PMC 4832440 . PMID 26811245. doi:10.1111/ijcp.12771.
Barak LS, Salahpour A, Zhang X, Masri B, Sotnikova TD, Ramsey AJ, et al. Pharmacological characterization of membrane-expressed human trace amine-associated receptor 1 (TAAR1) by a bioluminescence resonance energy transfer cAMP biosensor. Molecular Pharmacology. September 2008, 74 (3): 585–594. PMC 3766527 . PMID 18524885. doi:10.1124/mol.108.048884. we confirmed agonistic activity at human TAAR1 of several other compounds, including the trace amines octopamine and tryptamine, the amphetamine derivatives l-amphetamine, d-methamphetamine, (+)-MDMA, and phentermine, and the catecholamine metabolites 3-MT and 4-MT (Bunzow et al., 2001; Lindemann and Hoener, 2005; Reese et al., 2007; Wainscott et al., 2007; Wolinsky et al., 2007; Xie and Miller, 2007; Xie et al., 2007).
Rothman RB, Baumann MH, Dersch CM, Romero DV, Rice KC, Carroll FI, Partilla JS. Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse. January 2001, 39 (1): 32–41. PMID 11071707. S2CID 15573624. doi:10.1002/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3.
Weigle DS. Pharmacological therapy of obesity: past, present, and future. The Journal of Clinical Endocrinology and Metabolism. June 2003, 88 (6): 2462–2469. PMID 12788841. doi:10.1210/jc.2003-030151 .
Rueda-Clausen CF, Padwal RS, Sharma AM. New pharmacological approaches for obesity management. Nature Reviews. Endocrinology. August 2013, 9 (8): 467–478 [2024-01-03]. PMID 23752772. S2CID 20072687. doi:10.1038/nrendo.2013.113. （原始内容存档 (PDF)于2021-08-28）.

nytimes.com

Pollack A. Diet Treatment, Already in Use, to Get F.D.A. Review. The New York Times. 2012-02-16 [2024-01-03]. （原始内容存档于2017-09-16）.

semanticscholar.org

api.semanticscholar.org

Rothman RB, Baumann MH, Dersch CM, Romero DV, Rice KC, Carroll FI, Partilla JS. Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin. Synapse. January 2001, 39 (1): 32–41. PMID 11071707. S2CID 15573624. doi:10.1002/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3.
Rueda-Clausen CF, Padwal RS, Sharma AM. New pharmacological approaches for obesity management. Nature Reviews. Endocrinology. August 2013, 9 (8): 467–478 [2024-01-03]. PMID 23752772. S2CID 20072687. doi:10.1038/nrendo.2013.113. （原始内容存档 (PDF)于2021-08-28）.

tga.gov.au

ebs.tga.gov.au

METERMINE (Phentermine) (PDF). TGA eBusiness Services. iNova Pharmaceuticals (Australia) Pty Limited. 2013-07-22 [2013-11-16]. （原始内容存档于2016-10-13）.

web.archive.org

Phentermine Monograph for Professionals. Drugs.com. American Society of Health-System Pharmacists. [2019-04-13]. （原始内容存档于2019-06-07）.
METERMINE (Phentermine) (PDF). TGA eBusiness Services. iNova Pharmaceuticals (Australia) Pty Limited. 2013-07-22 [2013-11-16]. （原始内容存档于2016-10-13）.
Anvisa. RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control]. Diário Oficial da União. 2023-03-31 (2023-04-04) [2023-08-16]. （原始内容存档于2023-08-03）（巴西葡萄牙语）.
Phentermine and topiramate Uses, Side Effects & Warnings. Drugs.com. [2019-04-13]. （原始内容存档于2019-04-13）（英语）.
Phentermine Use During Pregnancy. Drugs.com. [2019-04-13]. （原始内容存档于2019-04-13）（英语）.
The Top 300 of 2020. ClinCalc. [2022-10-07]. （原始内容存档于2021-02-12）.
Phentermine - Drug Usage Statistics. ClinCalc. [2022-10-07]. （原始内容存档于2020-09-22）.
Bagchi D, Preuss HG. Obesity: Epidemiology, Pathophysiology, and Prevention Second. CRC Press. 2012: 314 [2024-01-03]. ISBN 9781439854259. （原始内容存档于2023-12-23）（英语）.
Phentermine label at FDA (Last updated: January 2012). FDA. [2016-10-13]. （原始内容存档 (PDF)于2017-01-18）.
FDA Announces Withdrawal Fenfluramine and Dexfenfluramine (Fen-Phen). Fda.gov. [2013-07-12]. （原始内容存档于2009-11-04）.
Convention on Psychotropic Substances 互联网档案馆的存檔，存档日期2014-03-14.
Rueda-Clausen CF, Padwal RS, Sharma AM. New pharmacological approaches for obesity management. Nature Reviews. Endocrinology. August 2013, 9 (8): 467–478 [2024-01-03]. PMID 23752772. S2CID 20072687. doi:10.1038/nrendo.2013.113. （原始内容存档 (PDF)于2021-08-28）.
Pollack A. Diet Treatment, Already in Use, to Get F.D.A. Review. The New York Times. 2012-02-16 [2024-01-03]. （原始内容存档于2017-09-16）.
FDA approves weight-management drug Qsymia. FDA. 2012-07-17 [2024-01-03]. （原始内容存档于2017-01-18）.
International brands for phentermine. Drugs.com. [2016-10-13]. （原始内容存档于2016-10-13）.

zenodo.org

Rueda-Clausen CF, Padwal RS, Sharma AM. New pharmacological approaches for obesity management. Nature Reviews. Endocrinology. August 2013, 9 (8): 467–478 [2024-01-03]. PMID 23752772. S2CID 20072687. doi:10.1038/nrendo.2013.113. （原始内容存档 (PDF)于2021-08-28）.